A Post-Market Domestic (US) and International Data Collection to Assess the Optetrak Knee System
Patient outcomes data is important for assessing the post-market safety and effectiveness of orthopedic medical devices. The purpose of this study is to collect clinical and patient outcomes and survivorship data for patients who have received or will receive a Optetrak® knee prosthesis manufactured or distributed by Exactech Inc (Gainesville, Florida, USA).
Study Type
OBSERVATIONAL
Enrollment
4,588
Total Knee Arthroplasty using Exactech's Optetrak branded components.
Fallon Clinic
Worcester, Massachusetts, United States
Nevada Orthopaedic and Spine Center
Las Vegas, Nevada, United States
Medical University South Carolina
Charleston, South Carolina, United States
Knee Society Score
(KSS) - validated outcome score
Time frame: Preoperative
Knee Society Score
(KSS) - validated outcome score
Time frame: 6 month postoperative
Knee Society Score
(KSS) - validated outcome score
Time frame: annually through study completion, maximum of 10-years
Hospital for Special Surgery Knee Score
(HSS) - validated outcome score
Time frame: Preoperative
Hospital for Special Surgery Knee Score
(HSS) - validated outcome score
Time frame: 6 month postoperative
Hospital for Special Surgery Knee Score
(HSS) - validated outcome score
Time frame: annually through study completion, maximum of 10-years
Oxford Knee Score
(OKS) - validated outcome score
Time frame: Preoperative
Oxford Knee Score
(OKS) - validated outcome score
Time frame: 6 month postoperative
Oxford Knee Score
(OKS) - validated outcome score
Time frame: annually through study completion, maximum of 10-years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.